review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1031341215 |
P356 | DOI | 10.1007/S10545-006-0269-0 |
P698 | PubMed publication ID | 16763900 |
P2093 | author name string | T J de Koning | |
P2860 | cites work | Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency | Q41926212 |
Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality | Q44674034 | ||
Kinetics of neutral amino acid transport across the blood-brain barrier | Q48186517 | ||
Sphingolipid metabolites in neural signalling and function | Q81077831 | ||
Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine | Q23923989 | ||
Characterization and localization of a human serine racemase | Q24296479 | ||
Mutations responsible for 3-phosphoserine phosphatase deficiency | Q24301799 | ||
3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis | Q24316377 | ||
Phosphoserine phosphatase deficiency in a patient with Williams syndrome | Q24517932 | ||
Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesis | Q24538921 | ||
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor | Q24675924 | ||
Enzymes of serine metabolism in normal, developing and neoplastic rat tissues | Q28259473 | ||
3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome | Q33921711 | ||
V490M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme | Q34105963 | ||
Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency | Q34378259 | ||
Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. | Q34418174 | ||
Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology | Q34955724 | ||
Serine-deficiency syndromes | Q35691381 | ||
Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids | Q35784910 | ||
Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids | Q41922766 | ||
Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings | Q41923426 | ||
Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency | Q41923480 | ||
P433 | issue | 2-3 | |
P921 | main subject | serine deficiency | Q18553425 |
P304 | page(s) | 347-351 | |
P577 | publication date | 2006-04-01 | |
P1433 | published in | Journal of Inherited Metabolic Disease | Q6295359 |
P1476 | title | Treatment with amino acids in serine deficiency disorders | |
P478 | volume | 29 |